NOS2 and chronic myelogenous leukemia, BCR-ABL1 positive: Further, CML induces NF-κB/p38/MAPK-dependent signaling transduction pathways, activating inducible nitric oxide synthase (iNOS) and, later, elevating NO formation (46).